The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years.
about
Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control studyFlexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individualsRisk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trialThe science and politics of colorectal cancer screening.Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals.Health disparities in colorectal cancer among racial and ethnic minorities in the United StatesThe value of models in informing resource allocation in colorectal cancer screening: the case of The NetherlandsExpert opinions and scientific evidence for colonoscopy key performance indicatorsColorectal Cancer Screening in Average Risk Populations: Evidence SummaryPolymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study.Association between cigarette smoking, APC mutations and the risk of developing sporadic colorectal adenomas and carcinomas.The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas.Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomasEndoscopy, morphology, morphometry and molecular markers: predicting cancer risk in colorectal adenoma.Collagen mRNA levels changes during colorectal cancer carcinogenesis.Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.Primary and secondary prevention of colorectal cancerSeptin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland.Likelihood of missed and recurrent adenomas in the proximal versus the distal colonTesting for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task groupCRC screening: review of the evidence and suggestions on when and how to move on from randomized trials to screening programmes.Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.A colorectal cancer screening program in an underserved, ethnically diverse population in Chicago, ILAppointments timed in proximity to annual milestones and compliance with screening: randomised controlled trial.Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study.UK key performance indicators and quality assurance standards for colonoscopyUptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation.Determinants of participation in colorectal cancer screening with faecal occult blood testing.Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer.The National Health Service Bowel Cancer Screening Program: the early years.Disparities in endoscopy use for colorectal cancer screening in the United States.The pathology of bowel cancer screening.
P2860
Q21260427-62F30C94-4593-4548-AB86-6FD5F990862CQ24197609-8C677B01-41E9-4665-B236-3D85ADC70E0FQ24653775-BB8AF95B-1F3D-434C-8353-9B55EEAD9E51Q25256548-4746BAA5-0755-496D-B130-7A3A198F3906Q25257551-29DCF2BA-D05C-49AB-AE42-1CFBB3D83DADQ26749003-2FAAADCB-6847-4E85-9492-C736DAC7D2C1Q27015647-C66B82A8-A270-4E3B-B2F3-94116836B66EQ28078507-DB2E9D57-29A1-4D65-9D40-FE940FA054A9Q28080279-1780DE44-FBC6-4D28-8B5E-7FDA9FB4CBD7Q33236760-1EE3A1D7-9D6C-4EC8-BD8B-68554D78FAF5Q33236882-6635B56F-E7AA-4BC3-BEBF-DA5123F75E35Q33248805-EF192D4D-FF7D-4E0D-9698-50FEFB7E04EAQ33254229-CB48CB86-4BF9-4467-83A3-37B2F495ADEEQ33302558-2CA90E4F-EB28-47FE-B044-6B0636B16D89Q33311408-6A0DC5A9-B3B6-4A5C-978C-E8F5B9CE6FFDQ33419668-2DB8ABFB-0E44-4C03-A788-DA4629BC53DAQ33440850-F0246354-DE39-497C-B563-473A4384DBB2Q33474548-661970CF-83EA-418B-B0D5-9263ACC29C4DQ33817521-4B037F76-305E-4A53-AE83-235980A3B9F6Q33976246-2529BF23-0789-4C23-B8FC-0E9A4C091D08Q34100603-37557FF6-85EA-4FD7-8F75-A1368E405D34Q34627515-FA59FC58-1CA3-47C0-85C2-EC1A60CDAF63Q35141554-65165884-4870-463A-884A-630CBC6EED34Q35596838-CA1CDD55-5854-45A3-9052-A14EDD857993Q35597425-7AF981D2-0A94-467C-AF38-0174FB1CB0E5Q35682174-95526CDB-10AA-413D-959F-7CBD2F02C61DQ35769041-CAABE12C-6A03-4E58-AE6A-79C7E5ADB1E0Q35831465-0771F81D-08F5-4910-B031-DE9CCC65F54EQ35835091-2170B609-64AD-4C79-B31E-E8009D1B7D4BQ36172676-BE7F6AD6-846D-476B-8023-C4ECD52FC168Q36997253-6AE9F66E-9A8B-4ECD-B51A-551209D14139Q37020668-4BE9E3B2-ACC0-4B5D-BC81-B0E1B39C01E8Q37241845-9D72EA0C-3B27-49DA-AC93-D8EB83F5C541Q37471724-FDD83B19-49BB-4751-8664-184CC4BFDD70Q37630575-F47D2658-D6C4-48FF-A5E2-8269D1DCED3AQ37656851-E53EAD54-DADB-4F4E-9842-5E59AD4B398EQ38045810-15C3F1BB-82F1-4BD8-AE0E-7D72173A0792Q38125254-8A50D474-78E9-4424-857E-8FC997F6B606Q38163885-28FC2759-4B30-46A9-AB82-8A289F14B47DQ38239871-571DDE85-F799-455B-BD2B-9155973014C2
P2860
The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The Norwegian Colorectal Cance ...... -up in age groups 50-64 years.
@en
The Norwegian Colorectal Cancer Prevention
@nl
type
label
The Norwegian Colorectal Cance ...... -up in age groups 50-64 years.
@en
The Norwegian Colorectal Cancer Prevention
@nl
prefLabel
The Norwegian Colorectal Cance ...... -up in age groups 50-64 years.
@en
The Norwegian Colorectal Cancer Prevention
@nl
P2093
P1476
The Norwegian Colorectal Cance ...... -up in age groups 50-64 years.
@en
P2093
P304
P356
10.1080/00365520310003002
P577
2003-06-01T00:00:00Z